161 related articles for article (PubMed ID: 32532932)
1. Should lCU COVID-19 patients empirically receive therapeutic doses of anticoagulant?
Piazza O
Infez Med; 2020 Jun; 28(suppl 1):4-5. PubMed ID: 32532932
[TBL] [Abstract][Full Text] [Related]
2. The rationale for Low-Molecular Weight Heparin (LMWH) use in SARS-CoV-2 infection.
Di Perri G
Infez Med; 2020 Jun; 28(suppl 1):52-56. PubMed ID: 32532939
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy for Prevention and Management of Thrombosis in COVID-19.
Hashemi A; Madhavan MV; Bikdeli B
Semin Thromb Hemost; 2020 Oct; 46(7):789-795. PubMed ID: 32820478
[No Abstract] [Full Text] [Related]
4. Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.
Schulman S
Semin Thromb Hemost; 2020 Oct; 46(7):772-776. PubMed ID: 32392613
[No Abstract] [Full Text] [Related]
5. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
Miesbach W; Makris M
Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology.
Chekkal M; Deba T; Hadjali S; Lamara H; Oulaa H; Zouai K; Hariti G
Transfus Clin Biol; 2020 Nov; 27(4):203-206. PubMed ID: 33022374
[TBL] [Abstract][Full Text] [Related]
7. Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19.
Spyropoulos AC; Levy JH; Ageno W; Connors JM; Hunt BJ; Iba T; Levi M; Samama CM; Thachil J; Giannis D; Douketis JD;
J Thromb Haemost; 2020 Aug; 18(8):1859-1865. PubMed ID: 32459046
[No Abstract] [Full Text] [Related]
8. Incidence of heparin-induced thrombocytopenia in patients with 2019 coronavirus disease.
Lozano R; Franco ME
Med Clin (Barc); 2020 Nov; 155(9):409-410. PubMed ID: 32883507
[No Abstract] [Full Text] [Related]
9. Detection of anti-heparin-PF4 complex antibodies in COVID-19 patients on heparin therapy.
Dragonetti D; Guarini G; Pizzuti M
Blood Transfus; 2020 Jul; 18(4):328. PubMed ID: 32697931
[No Abstract] [Full Text] [Related]
10. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.
Ahmed S; Zimba O; Gasparyan AY
Clin Rheumatol; 2020 Sep; 39(9):2529-2543. PubMed ID: 32654082
[TBL] [Abstract][Full Text] [Related]
11. Coagulation changes and thromboembolic risk in COVID-19 obstetric patients.
Benhamou D; Keita H; Ducloy-Bouthors AS;
Anaesth Crit Care Pain Med; 2020 Jun; 39(3):351-353. PubMed ID: 32437961
[No Abstract] [Full Text] [Related]
12. Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19.
Horowitz NA; Brenner B
Semin Thromb Hemost; 2020 Oct; 46(7):785-788. PubMed ID: 32785920
[No Abstract] [Full Text] [Related]
13. Heparin dosage, level, and resistance in SARS-CoV2 infected patients in intensive care unit.
Novelli C; Borotto E; Beverina I; Punzi V; Radrizzani D; Brando B
Int J Lab Hematol; 2021 Dec; 43(6):1284-1290. PubMed ID: 33855802
[TBL] [Abstract][Full Text] [Related]
14. Current Perspectives of Anticoagulation in Patients With COVID-19.
Gavioli EM; Sikorska G; Man A; Rana J; Vider E
J Cardiovasc Pharmacol; 2020 Aug; 76(2):146-150. PubMed ID: 32569013
[TBL] [Abstract][Full Text] [Related]
15. Immune-Mediated Coagulopathy in COVID-19 Infection.
Vadasz Z; Brenner B; Toubi E
Semin Thromb Hemost; 2020 Oct; 46(7):838-840. PubMed ID: 32877959
[No Abstract] [Full Text] [Related]
16. Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy.
James AH; Brancazio LR; Ortel TL
Clin Adv Hematol Oncol; 2005 Mar; 3(3):187-97. PubMed ID: 16166990
[TBL] [Abstract][Full Text] [Related]
17. Venous Thromboembolism and Heparin Use in COVID-19 Patients: Juggling between Pragmatic Choices, Suggestions of Medical Societies and the Lack of Guidelines.
Porfidia A; Pola R
J Thromb Thrombolysis; 2020 Jul; 50(1):68-71. PubMed ID: 32367471
[No Abstract] [Full Text] [Related]
18. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
Kreidieh F; Temraz S
Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
[TBL] [Abstract][Full Text] [Related]
19. Viral Coagulopathy in Patients With COVID-19: Treatment and Care.
Kipshidze N; Dangas G; White CJ; Kipshidze N; Siddiqui F; Lattimer CR; Carter CA; Fareed J
Clin Appl Thromb Hemost; 2020; 26():1076029620936776. PubMed ID: 32687449
[TBL] [Abstract][Full Text] [Related]
20. Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients.
Ahmed SI; Khan S
Curr Probl Cardiol; 2020 Sep; 45(9):100648. PubMed ID: 32703535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
